AFP and hepatocellular carcinoma: Upon combining the AFP, a miRNA panel (miR-122, miR-885-5p, miR-221, and miR-22) was reported capable of distinguishing early HCC from liver cirrhosis, chronic hepatitis C, and healthy subjects, and therefore was recommended for clinical use in early detection of HCC by this study [72].